{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:01:34Z","timestamp":1784617294711,"version":"3.55.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The use of dietary supplements by patients with chronic liver disease is prevalent and rising. Despite the known risks of dietary supplements, including hepatotoxicity, adulteration, and contamination, patients with chronic liver disease often turn to dietary supplements to support their liver and\/or overall health but are not necessarily empowered with the information or guidance from their liver practitioner to do so. This article provides practitioners with a framework for balancing the risks and benefits of dietary supplements in patients with chronic liver disease, offering examples of independent resources and certifications to use this framework in clinical practice. We offer 3 common clinical scenarios to highlight how the use of this framework can improve communication and decision-making in clinical practice. By adapting principles from Integrative Medicine, this article advocates for a patient-centered approach to dietary supplements in patients with chronic liver disease, encouraging open dialogue between clinicians and their patients to facilitate informed decision-making and personalized care.<\/jats:p>","DOI":"10.1097\/hc9.0000000000000552","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T14:01:17Z","timestamp":1729778477000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["A patient-centered approach to dietary supplements for patients with chronic liver disease"],"prefix":"10.1097","volume":"8","author":[{"given":"Jennifer C.","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California-San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Ring","sequence":"additional","affiliation":[{"name":"Osher Center for Integrative Health at Northwestern University, Chicago, Illinois, USA"},{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Dhruva","sequence":"additional","affiliation":[{"name":"Osher Center for Integrative Health, University of California-San Francisco, San Francisco, California, USA"},{"name":"Department of Medicine, Division of Hematology and Oncology, University of California-San Francisco, San Francisco, California, USA"},{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Y.","family":"Yeh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"},{"name":"Osher Center for Integrative Health, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"R2-20241203","article-title":"Dietary supplement use among adults: United States, 2017\u20132018","author":"Mishra","year":"2021","journal-title":"Natl Cent Health Stat Data Brief"},{"key":"R3-20241203","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/jgs.18305","article-title":"Dietary supplement and complementary and alternative medicine use among older adults in Australia and the United States","volume":"71","author":"Fravel","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"R8-20241203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0115426506021003255","article-title":"The use of selected nutrition supplements and complementary and alternative medicine in liver disease","volume":"21","author":"Hanje","year":"2006","journal-title":"Nutr Clin Pract"},{"key":"R9-20241203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/1534735414550038","article-title":"Dietary supplement use among patients with hepatocellular carcinoma","volume":"14","author":"Lee","year":"2015","journal-title":"Integr Cancer Ther"},{"key":"R10-20241203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jgh.15221","article-title":"Systematic review with meta\u2010analysis: The effect of vitamin E supplementation in adult patients with non\u2010alcoholic fatty liver disease","volume":"36","author":"Vadarlis","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R11-20241203","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3390\/nu15173733","article-title":"The effect of vitamin E supplementation on serum aminotransferases in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis","volume":"15","author":"Vogli","year":"2023","journal-title":"Nutrients"},{"key":"R12-20241203","first-page":"CD001939","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","volume":"1","author":"Gluud","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20241203","first-page":"CD008716","article-title":"Probiotics for people with hepatic encephalopathy","volume":"2","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20241203","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/liv.13005","article-title":"Probiotics are helpful in hepatic encephalopathy: A meta\u2010analysis of randomized trials","volume":"36","author":"Saab","year":"2016","journal-title":"Liver Int"},{"key":"R15-20241203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamainternmed.2013.2299","article-title":"Why US adults use dietary supplements","volume":"173","author":"Bailey","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R16-20241203","doi-asserted-by":"crossref","first-page":"23743735221125439","DOI":"10.1177\/23743735221125439","article-title":"Impact of patient engagement on healthcare quality: A scoping review","volume":"9","author":"Marzban","year":"2022","journal-title":"J Patient Exp"},{"key":"R17-20241203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13012-018-0784-z","article-title":"Engaging patients to improve quality of care: A systematic review","volume":"13","author":"Bombard","year":"2018","journal-title":"Implement Sci IS"},{"key":"R18-20241203","doi-asserted-by":"crossref","first-page":"e0417","DOI":"10.1097\/HC9.0000000000000417","article-title":"Complementary and alternative medicines and liver disease","volume":"8","author":"Philips","year":"2024","journal-title":"Hepatol Commun"},{"key":"R19-20241203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"R20-20241203","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/toxins12120782","article-title":"Presence of mycotoxins in milk thistle (Silybum marianum) food supplements: A review","volume":"12","author":"Pickova","year":"2020","journal-title":"Toxins"},{"key":"R21-20241203","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/19440049.2012.664788","article-title":"Occurrence of aflatoxins in milk thistle herbal supplements","volume":"29","author":"Tournas","year":"2012","journal-title":"Food Addit Contam Part Chem Anal Control Expo Risk Assess"},{"key":"R22-20241203","doi-asserted-by":"crossref","first-page":"e183337","DOI":"10.1001\/jamanetworkopen.2018.3337","article-title":"Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings","volume":"1","author":"Tucker","year":"2018","journal-title":"JAMA Netw Open"},{"key":"R25-20241203","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep4.1346","article-title":"The contents of herbal and dietary supplements implicated in liver injury in the United States are frequently mislabeled","volume":"3","author":"Navarro","year":"2019","journal-title":"Hepatol Commun"},{"key":"R26-20241203","doi-asserted-by":"crossref","first-page":"22305","DOI":"10.1038\/s41598-022-24830-1","article-title":"Dietary supplement mislabelling: Case study on selected slimming products by developing a green isocratic HPLC method for their quality control","volume":"12","author":"El Azab","year":"2022","journal-title":"Sci Rep"},{"key":"R27-20241203","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1017\/S1368980021000665","article-title":"Dietary supplements in the USA: Problematic trends","volume":"24","author":"Denham","year":"2021","journal-title":"Public Health Nutr"},{"key":"R28-20241203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1389557523666230328153417","article-title":"Therapeutic potentials of aconite-like alkaloids: Bioinformatics and experimental approaches","volume":"24","author":"Mares","year":"2024","journal-title":"Mini Rev Med Chem"},{"key":"R30-20241203","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ajg.2016.114","article-title":"Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury","volume":"111","author":"Hillman","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R31-20241203","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jceh.2020.11.002","article-title":"The Indian network of drug-induced liver injury: Etiology, clinical features, outcome and prognostic markers in 1288 patients","volume":"11","author":"Devarbhavi","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"R32-20241203","doi-asserted-by":"crossref","first-page":"021","DOI":"10.1055\/s-0038-1623518","article-title":"Hepatic damage by natural remedies","volume":"38","author":"Andrade","year":"2018","journal-title":"Semin Liver Dis"},{"key":"R33-20241203","doi-asserted-by":"crossref","first-page":"e0270","DOI":"10.1097\/HC9.0000000000000270","article-title":"Ashwagandha-induced liver injury\u2014A case series from India and literature review","volume":"7","author":"Philips","year":"2023","journal-title":"Hepatol Commun"},{"key":"R34-20241203","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2022.09.026","article-title":"Liver injury associated with turmeric\u2014A growing problem: Ten cases from the Drug-Induced Liver Injury Network [DILIN]","volume":"136","author":"Halegoua-DeMarzio","year":"2023","journal-title":"Am J Med"},{"key":"R35-20241203","doi-asserted-by":"crossref","first-page":"e00941","DOI":"10.14309\/crj.0000000000000941","article-title":"Turmeric-associated drug-induced liver injury","volume":"9","author":"Sunagawa","year":"2022","journal-title":"ACG Case Rep J"},{"key":"R36-20241203","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bcp.14460","article-title":"Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports","volume":"87","author":"Lombardi","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R40-20241203","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamainternmed.2024.1836","article-title":"Severe acute liver injury after hepatotoxic medication initiation in real-world data","volume":"184","author":"Torgersen","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R41-20241203","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/0003-4819-137-11-200212030-00010","article-title":"Advising patients who seek complementary and alternative medical therapies for cancer","volume":"137","author":"Weiger","year":"2002","journal-title":"Ann Intern Med"},{"key":"R42-20241203","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jand.2015.11.003","article-title":"Quality certification programs for dietary supplements","volume":"116","author":"Akabas","year":"2016","journal-title":"J Acad Nutr Diet"},{"key":"R43-20241203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.healthpol.2008.09.003","article-title":"Traditional Chinese medicine in the Chinese health care system","volume":"90","author":"Xu","year":"2009","journal-title":"Health Policy Amst Neth"},{"key":"R47-20241203","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-137-8-200210150-00010","article-title":"Ethical considerations of complementary and alternative medical therapies in conventional medical settings","volume":"137","author":"Adams","year":"2002","journal-title":"Ann Intern Med"},{"key":"R48-20241203","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/ptr.6171","article-title":"Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases","volume":"32","author":"Abenavoli","year":"2018","journal-title":"Phytother Res PTR"},{"key":"R49-20241203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.20787","article-title":"Milk thistle and chronic liver disease","volume":"42","author":"Hoofnagle","year":"2005","journal-title":"Hepatology"},{"key":"R51-20241203","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver disease","volume":"113","author":"Jacobs","year":"2002","journal-title":"Am J Med"},{"key":"R52-20241203","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jama.2012.8265","article-title":"Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: A randomized controlled trial","volume":"308","author":"Fried","year":"2012","journal-title":"JAMA"},{"key":"R53-20241203","first-page":"e47608","article-title":"Impact of silymarin supplements on liver enzyme levels: A systematic review","volume":"15","author":"Calderon Martinez","year":"2023","journal-title":"Cureus"},{"key":"R54-20241203","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.aohep.2023.101174","article-title":"Administration of silymarin in NAFLD\/NASH: A systematic review and meta-analysis","volume":"29","author":"Li","year":"2024","journal-title":"Ann Hepatol"},{"key":"R55-20241203","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/nu11092147","article-title":"Dietary curcumin: Correlation between bioavailability and health potential","volume":"11","author":"Dei Cas","year":"2019","journal-title":"Nutrients"},{"key":"R56-20241203","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ptr.6542","article-title":"The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials","volume":"34","author":"Baziar","year":"2020","journal-title":"Phytother Res PTR"},{"key":"R57-20241203","doi-asserted-by":"crossref","first-page":"103025","DOI":"10.1016\/j.ctim.2024.103025","article-title":"Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials","volume":"80","author":"Ebrahimzadeh","year":"2024","journal-title":"Complement Ther Med"},{"key":"R58-20241203","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00365521.2019.1611917","article-title":"Efficacy and safety of curcumin in primary sclerosing cholangitis: An open label pilot study","volume":"54","author":"Eaton","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"R59-20241203","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.25551","article-title":"Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011","volume":"55","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"R60-20241203","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/antiox9121283","article-title":"N-acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in NAFLD: A comprehensive analysis of the literature","volume":"9","author":"Dludla","year":"2020","journal-title":"Antioxid Basel Switz"},{"key":"R62-20241203","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamainternmed.2024.1833","article-title":"Rethinking drug-induced liver injury\u2014A new era of pharmacovigilance","volume":"184","author":"Zhang","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R63-20241203","doi-asserted-by":"crossref","first-page":"e0135","DOI":"10.1097\/HC9.0000000000000135","article-title":"Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus","volume":"7","author":"Patel","year":"2023","journal-title":"Hepatol Commun"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HC9.0000000000000552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:10:12Z","timestamp":1733249412000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HC9.0000000000000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/hc9.0000000000000552","relation":{},"ISSN":["2471-254X"],"issn-type":[{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"2024-07-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}